- What other names is Kudzu known by?
- What is Kudzu?
- How does Kudzu work?
- Are there safety concerns?
- Are there any interactions with medications?
- Dosing considerations for Kudzu.
Bidarikand, Daidzein, Dolichos hirsutus, Dolichos lobatus, Fen Ke, Fenge, Gange, Ge Gen, Gegen, Indian Kudzu, Isoflavone, Isoflavones, Japanese Arrowroot, Kakkon, Kudsu, Kudzu Vine, Kwaao Khruea, Mealy Kudzu, Neustanthus chinensis, Pachyrhizus thunbergianus, Pueraria, Pueraria candollei, Pueraria hirsuta, Pueraria lobata, Pueraria lobata var. chinensis, Pueraria mirifica, Pueraria montana var. lobata, Pueraria montana var. thomsonii, Pueraria pseudohirsuta, Pueraria Root, Pueraria thomsonii, Pueraria thunbergiana, Pueraria tuberosa, Radix Puerariae, Red Indian Kudzu, Thai Kudzu Root Extract, Vidarikand, Vigne Kudzu, White Indian Kudzu, Yege.
Kudzu is a vine. Under the right growing conditions, it spreads easily, covering virtually everything that doesn't move out of its path. Kudzu was introduced in North America in 1876 in the southeastern U.S. to prevent soil erosion. But kudzu spread quickly and overtook farms and buildings, leading some to call to kudzu "the vine that ate the South.”
Kudzu's root, flower, and leaf are used to make medicine. It has been used in Chinese medicine since at least 200 BC. As early as 600 AD, it was used to treat alcoholism.
Today, kudzu is used to treat alcoholism and to reduce symptoms of alcohol hangover, including headache, upset stomach, dizziness, and vomiting. Kudzu is also used for heart and circulatory problems, including high blood pressure, irregular heartbeat, and chest pain; for upper respiratory problems including sinus infections, the common cold, hay fever, flu, and swine flu; and for skin problems, including allergic skin rash, itchiness, and psoriasis.
Some people use kudzu for menopause symptoms, muscle pain, measles, dysentery, stomach pain (gastritis), fever, diarrhea, thirst, neck stiffness, and to promote sweating. Other oral uses include treatment of polio myelitis, encephalitis, migraine, deafness, diabetes, and traumatic injuries.
Insufficient Evidence to Rate Effectiveness for...
- Alcoholism. Early research suggests that heavy drinkers who take kudzu extract for 7 days consume less beer when given a chance to drink. But kudzu doesn't seem to decrease the craving for alcohol or improve sobriety in long-term alcoholics.
- Chest pains. Some early research suggests that puerarin, a chemical in kudzu, might improve signs and symptoms of chest pain when taken by mouth or injected intravenously (by IV). Some evidence suggests that using IV puerarin along with usual treatment might be more effective than usual treatment alone. However, studies on puerarin are generally of poor quality and might not be reliable. Puerarin injection products are not available in North America.
- Preventing chest pain during a procedure called percutaneous transluminal coronary angioplasty (PTCA). Early research suggests that injecting 200 mL of puerarin, a chemical in kudzu, intravenously (by IV) one week before and immediately prior to percutaneous transluminal coronary angioplasty (PTCA) might reduce episodes of chest pain. Puerarin injection products are not available in North America.
- Coronary heart disease (CHD). Early research suggests that injecting 500 mL of puerarin, a chemical in kudzu, intravenously (by IV) once daily for 3 weeks might reduce “bad” low-density lipoprotein (LDL) cholesterol, increase “good” high-density lipoprotein (HDL) cholesterol, and reduce pre-meal insulin levels in people with coronary heart disease. Puerarin injection products are not available in North America.
- Diabetes. Early research suggests that taking puerarin, a chemical in kudzu, 750 mg daily by mouth along with the diabetes medication rosiglitazone (Avandia) reduces blood sugar in patients with type 2 diabetes. However, injecting puerarin intravenously (by IV) does not appear to reduce blood sugar. Puerarin injection products are not available in North America.
- Kidney disease in people with diabetes (diabetic nephropathy). Early research suggests that taking puerarin, a chemical in kudzu, 750 mg daily by mouth along with the diabetes medication rosiglitazone (Avandia) improves kidney function in people with diabetic nephropathy.
- Problems with the retina of the eye in people with diabetes (diabetic retinopathy). Some research suggests that injecting puerarin, a chemical in kudzu, intravenously (by IV) does not improve vision in people with diabetic retinopathy. Puerarin injection products are not available in North America.
- Exercise performance. Early research suggests that taking a combination supplement containing kudzu isoflavones along with other ingredients might improve exercise performance in some people.
- Heart failure. Early research suggests that taking puerarin, a chemical in kudzu, 400 mg/day by mouth for 10 days might improve heart function in people with heart failure.
- Stroke. Some early research suggests that taking puerarin, a chemical in kudzu, alone or with aspirin, might improve brain function in some people after stroke. However, other research shows that injecting puerarin intravenously (by IV) does not reduce death or dependency after a stroke.
- Low back pain. Early research suggests that injections of puerarin, a chemical in kudzu, might reduce pain in some people with low back pain. Puerarin injection products are not available in North America.
- Symptoms of menopause. Research on kudzu for symptoms of menopause has been conflicting. Some research suggests that taking kudzu by mouth can reduce hot flashes and improve vaginal dryness in women going through menopause. Other research shows that taking kudzu does not affect sex hormone levels, blood fat levels, bone density, or other symptoms of menopause. However, it might have a positive effect on the mental abilities of postmenopausal women.
- Heart attack (myocardial infarction). Early research suggests that injecting puerarin, a chemical in kudzu, intravenously (by IV) along with usual treatment might help some people after a heart attack. Puerarin injection products are not available in North America.
- Weight loss. Early research suggests that taking kudzu extract 300 mg by mouth daily for 12 weeks reduces body fat and body mass index (BMI) in people who are obese. However, taking kudzu extract 200 mg daily does not appear to have the same effects.
- Symptoms of alcohol hangover (headache, upset stomach, dizziness and vomiting).
- Muscle pain.
- Stomach inflammation (gastritis).
- Neck stiffness.
- Promoting sweating (diaphoretic).
- High blood pressure.
- Abnormal heart rate and rhythm.
- Other conditions.
There is information that suggests kudzu contains ingredients that counteract alcohol. It might also have effects like estrogen. Chemicals in kudzu might also increase blood circulation in the heart and brain.
Kudzu is POSSIBLY SAFE for most people when taken by mouth appropriately for up to 4 months or when injected intravenously (by IV) for up to 20 days.
No side effects have been reported in clinical studies when kudzu is taken by mouth. There is, however, one case report of allergic reaction following use of a combination herbal product containing kudzu (Kakkonto). Another report suggests that taking kudzu root by mouth might cause liver damage.
When given by IV, the kudzu ingredient, puerarin, has been associated with itching and nausea. It has also caused red cells to break inside blood vessels.
Special Precautions & Warnings:Pregnancy and breast-feeding: There is not enough reliable information about the safety of taking kudzu if you are pregnant or breast feeding. Stay on the safe side and avoid use.
Bleeding or blood clotting disorders: Kudzu might slow blood clotting. It might make bleeding and blood clotting disorders worse, and it might also interfere with medications used as treatment.
Cardiovascular (heart and blood vessel) conditions: There is a concern that kudzu might interfere with cardiovascular treatments. Kudzu extracts seem to lower blood pressure and affect heart rhythm in animals.
Hormone-sensitive condition such as breast cancer, uterine cancer, ovarian cancer, endometriosis, or uterine fibroids: Kudzu might act like estrogen. If you have any condition that might be made worse by exposure to estrogen, don't use kudzu.
Liver disease: There is some concern that taking kudzu might harm the liver. In theory, kudzu might make liver diseases, such as hepatitis, worse. People with liver disease or a history of liver disease should avoid kudzu.
Surgery: Kudzu might affect blood sugar levels and might interfere with blood sugar control during and after surgery. Stop taking kudzu at least 2 weeks before a scheduled surgery.
Birth control pills (Contraceptive drugs)Interaction Rating: Moderate Be cautious with this combination.Talk with your health provider.
Some birth control pills contain estrogen. Kudzu might have some of the same effects as estrogen. But kudzu isn't as strong as the estrogen in birth control pills. Taking kudzu along with birth control pills might decrease the effectiveness of birth control pills. If you take birth control pills along with kudzu, use an additional form of birth control such as a condom.
EstrogensInteraction Rating: Moderate Be cautious with this combination.Talk with your health provider.
The body breaks down caffeine (contained in kudzu) to get rid of it. Estrogens can decrease how quickly the body breaks down caffeine. Decreasing the breakdown of caffeine can cause jitteriness, headache, fast heartbeat, and other side effects. If you take estrogens, limit your caffeine intake.
Some estrogen pills include conjugated equine estrogens (Premarin), ethinyl estradiol, estradiol, and others.
Medications that can harm the liver (Hepatotoxic drugs)Interaction Rating: Moderate Be cautious with this combination.Talk with your health provider.
Kudzu might harm the liver. In theory, taking kudzu along with medication that might also harm the liver can increase the risk of liver damage.
Some medications that can harm the liver include acarbose (Precose, Prandase), amiodarone (Cordarone), atorvastatin (Lipitor), azathioprine (Imuran), carbamazepine (Tegretol), cerivastatin (Baycol), diclofenac (Voltaren), felbamate (Felbatol), fenofibrate (Tricor), fluvastatin (Lescol), gemfibrozil (Lopid), isoniazid, itraconazole, (Sporanox), ketoconazole (Nizoral), leflunomide (Arava), lovastatin (Mevacor), methotrexate (Rheumatrex), nevirapine (Viramune), niacin, nitrofurantoin (Macrodantin), pioglitazone (Actos), pravastatin (Pravachol), pyrazinamide, rifampin (Rifadin), ritonavir (Norvir), rosiglitazone (Avandia), simvastatin (Zocor), tacrine (Cognex), tamoxifen, terbinafine (Lamisil), valproic acid, and zileuton (Zyflo).
Medications that slow blood clotting (Anticoagulant / Antiplatelet drugs)Interaction Rating: Moderate Be cautious with this combination.Talk with your health provider.
Kudzu might slow blood clotting. Taking kudzu along with medications that also slow clotting might increase the chances of bruising and bleeding.
Some medications that slow blood clotting include aspirin, clopidogrel (Plavix), diclofenac (Voltaren, Cataflam, others), ibuprofen (Advil, Motrin, others), naproxen (Anaprox, Naprosyn, others), dalteparin (Fragmin), enoxaparin (Lovenox), heparin, warfarin (Coumadin), and others.
Methotrexate (MTX, Rheumatrex)Interaction Rating: Moderate Be cautious with this combination.Talk with your health provider.
Kudzu might decrease how fast the body gets rid of methotrexate (Rheumatrex). This might increase the risk of methotrexate side effects.
Tamoxifen (Nolvadex)Interaction Rating: Moderate Be cautious with this combination.Talk with your health provider.
Some types of cancer are affected by hormones in the body. Estrogen-sensitive cancers are cancers that are affected by estrogen levels in the body. Tamoxifen (Nolvadex) is used to help treat and prevent these types of cancer. Kudzu seems to also affect estrogen levels in the body. By affecting estrogen in the body, kudzu might decrease the effectiveness of tamoxifen (Nolvadex). Do not take kudzu if you are taking tamoxifen (Nolvadex).
Medications for diabetes (Antidiabetes drugs)Interaction Rating: Minor Be cautious with this combination.Talk with your health provider.
Kudzu might decrease blood sugar. Diabetes medications are also used to lower blood sugar. Taking kudzu along with diabetes medications might cause your blood sugar to go too low. Monitor your blood sugar closely. The dose of your diabetes medication might need to be changed.
Some medications used for diabetes include glimepiride (Amaryl), glyburide (DiaBeta, Glynase PresTab, Micronase), insulin, pioglitazone (Actos), rosiglitazone (Avandia), chlorpropamide (Diabinese), glipizide (Glucotrol), tolbutamide (Orinase), and others.
The appropriate dose of kudzu depends on several factors such as the user's age, health, and several other conditions. At this time there is not enough scientific information to determine an appropriate range of doses for kudzu. Keep in mind that natural products are not always necessarily safe and dosages can be important. Be sure to follow relevant directions on product labels and consult your pharmacist or physician or other healthcare professional before using.
Natural Medicines Comprehensive Database rates effectiveness based on scientific evidence according to the following scale: Effective, Likely Effective, Possibly Effective, Possibly Ineffective, Likely Ineffective, and Insufficient Evidence to Rate (detailed description of each of the ratings).
Health Solutions From Our Sponsors
Akita, H., Sowa, J., Makiura, M., Akamatsu, H., and Matsunaga, K. Maculopapular drug eruption due to the Japanese herbal medicine Kakkonto (kudzu or arrowroot decoction). Contact Dermatitis 2003;48(6):348-349. View abstract.
An, JR Zhang H Cai XZ Deng Q Fu J Sun Q. Effect observation of Puerarin injection for unstable angina pectoris. Chinese Journal of Clinical Pharmacology and Therapeutics 2001;6(3):2445.
Bae, H. S., Kim, Y. S., Cho, K. H., Lee, K. S., Kim, J. J., Lee, H. U., and Kim, D. H. Hepatoprotective activity of reduohanxiao-tang (yuldahanso-tang) is related to the inhibition of beta-glucuronidase. Am J Chin Med 2003;31(1):111-117. View abstract.
Bao, XM. Observation on curative effects of puerarin injecion in the patients with unstable angina pectoris. Medical Journal of Communications 2003;17(1):12-13.
Barnes, S., Prasain, J., D'Alessandro, T., Arabshahi, A., Botting, N., Lila, M. A., Jackson, G., Janle, E. M., and Weaver, C. M. The metabolism and analysis of isoflavones and other dietary polyphenols in foods and biological systems. Food Funct. 2011;2(5):235-244. View abstract.
Benlhabib, E., Baker, J. I., Keyler, D. E., and Singh, A. K. Composition, red blood cell uptake, and serum protein binding of phytoestrogens extracted from commercial kudzu-root and soy preparations. J Med Food 2002;5(3):109-123. View abstract.
Bennetau-Pelissero, C., Latonnelle, K. G., Lamothe, V., Shinkaruk-Poix, S., and Kaushik, S. J. Screening for oestrogenic activity of plant and food extracts using in vitro trout hepatocyte cultures. Phytochem.Anal. 2004;15(1):40-45. View abstract.
Bracken, B. K., Penetar, D. M., Maclean, R. R., and Lukas, S. E. Kudzu root extract does not perturb the sleep/wake cycle of moderate drinkers. J Altern Complement Med 2011;17(10):961-966. View abstract.
Carlson, S., Peng, N., Prasain, J. K., and Wyss, J. M. Effects of botanical dietary supplements on cardiovascular, cognitive, and metabolic function in males and females. Gend.Med 2008;5 Suppl A:S76-S90. View abstract.
Cervellati, R., Renzulli, C., Guerra, M. C., and Speroni, E. Evaluation of antioxidant activity of some natural polyphenolic compounds using the Briggs-Rauscher reaction method. J Agric.Food Chem. 12-18-2002;50(26):7504-7509. View abstract.
Chandeying, V. and Lamlertkittikul, S. Challenges in the conduct of Thai herbal scientific study: efficacy and safety of phytoestrogen, pueraria mirifica (Kwao Keur Kao), phase I, in the alleviation of climacteric symptoms in perimenopausal women. J Med Assoc Thai. 2007;90(7):1274-1280. View abstract.
Chandeying, V. and Sangthawan, M. Efficacy comparison of Pueraria mirifica (PM) against conjugated equine estrogen (CEE) with/without medroxyprogesterone acetate (MPA) in the treatment of climacteric symptoms in perimenopausal women: phase III study. J Med Assoc Thai. 2007;90(9):1720-1726. View abstract.
Chao JX, Ye M. Clinical study on Purerain for acute ischemic stroke. Guangdong Med J. 2004;4(3):38-39.
Chen, J., Xu, J., and Li, J. [Effect of puerarin on fibrinolytic activity and lipid peroxide in patients with coronary heart disease]. Zhongguo Zhong.Xi.Yi.Jie.He.Za Zhi. 1999;19(11):649-650. View abstract.
Chen, L., Bi, X. Y., Zhu, L. X., Qiu, Y. Q., Ding, S. J., and Deng, B. Q. [Flavonoids of puerarin versus tanshinone II A for ischemic stroke: a randomized controlled trial]. Zhong.Xi.Yi Jie.He.Xue Bao 2011;9(11):1215-1220. View abstract.
Chen, L., Chai, Q., Zhao, A., and Chai, X. [Effect of puerarin on cerebral blood flow in dogs]. Zhongguo Zhong.Yao Za Zhi. 1995;20(9):560-2, inside. View abstract.
Chen, W. C., Hayakawa, S., Yamamoto, T., Su, H. C., Liu, I. M., and Cheng, J. T. Mediation of beta-endorphin by the isoflavone puerarin to lower plasma glucose in streptozotocin-induced diabetic rats. Planta Med 2004;70(2):113-116. View abstract.
Choi, J., Shin, M. H., Park, K. Y., Lee, K. T., Jung, H. J., Lee, M. S., and Park, H. J. Effect of kaikasaponin III obtained from Pueraria thunbergiana flowers on serum and hepatic lipid peroxides and tissue factor activity in the streptozotocin-induced diabetic rat. J Med Food 2004;7(1):31-37. View abstract.
Choo, M. K., Park, E. K., Yoon, H. K., and Kim, D. H. Antithrombotic and antiallergic activities of daidzein, a metabolite of puerarin and daidzin produced by human intestinal microflora. Biol.Pharm.Bull. 2002;25(10):1328-1332. View abstract.
Deng MY. Clinical observation of 48 cases of puerarin for unstable angina pectoris. Hainan Medical Journal 2003;14(1):14-15.
Ding, R. B., Tian, K., Huang, L. L., He, C. W., Jiang, Y., Wang, Y. T., and Wan, J. B. Herbal medicines for the prevention of alcoholic liver disease: a review. J Ethnopharmacol. 12-18-2012;144(3):457-465. View abstract.
Dong PS, Liu YH Song RL Liu FX. Observation on curative effects of puerarin injection on unstable angina pectoris. Chinese Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care 1999;6(5):355-356.
Dong, K., Tao, Q. M., Xia, Q., Shan, Q. X., and Pan, G. B. [Endothelium-independent vasorelaxant effect of puerarin on rat thoracic aorta]. Zhongguo Zhong.Yao Za Zhi. 2004;29(10):981-984. View abstract.
Dong, L. P. and Wang, T. Y. Effects of puerarin against glutamate excitotoxicity on cultured mouse cerebral cortical neurons. Zhongguo Yao Li Xue.Bao. 1998;19(4):339-342. View abstract.
Duan, H. J., Liu, S. X., Zhang, Y. J., Liu, Q. J., He, N., and Li, Y. M. [Effects of puerarin on renal function, expressions of MMP-2 and TIMP-2 in diabetic rats]. Yao Xue.Xue.Bao. 2004;39(7):481-485. View abstract.
Duan, S., Li, Y. F., and Luo, X. L. [Effect of puerarin on heart function and serum oxidized-LDL in the patients with chronic cardiac failure]. Hunan.Yi.Ke.Da.Xue.Xue.Bao. 4-28-2000;25(2):176-178. View abstract.
Fan P, Wang L Liu QX. The application of puerarin in the treatment of unstable angina pectoris. Modern Journal of Integrated Chinese Traditional and Western Medicine 1999;8(12):1945-1946.
Fan, L. L., Sun, L. H., Li, J., Yue, X. H., Yu, H. X., and Wang, S. Y. The protective effect of puerarin against myocardial reperfusion injury. Study on cardiac function. Chin Med J (Engl.) 1992;105(1):11-17. View abstract.
Guo YJ, Ceng YW Zhao HF. Effect observation of puerarin for unstable angina pectoris. 2000, (5):716-7. Journal of Youjiang Medical College for Nationalities 2000;5:716-717.
Guo, X. G., Chen, J. Z., Zhang, X., and Xia, Q. [Effect of puerarin on L-type calcium channel in isolated rat ventricular myocytes]. Zhongguo Zhong.Yao Za Zhi. 2004;29(3):248-251. View abstract.
Hou, Q., Ao, X., Li, G., and Zhang, Y. [Puerarin combined with avandia for diabetic nephropathy]. Zhong.Nan.Da.Xue Xue Bao Yi Xue Ban. 2012;37(1):73-77. View abstract.
Hsu, H. H., Chang, C. K., Su, H. C., Liu, I. M., and Cheng, J. T. Stimulatory effect of puerarin on alpha1A-adrenoceptor to increase glucose uptake into cultured C2C12 cells of mice. Planta Med 2002;68(11):999-1003. View abstract.
Hu, H. T., Fen, F., and Ding, M. P. [Effects of puerarin with aspirin on the markers of damaged vascular endothelial cells in patients with acute cerebral infarction]. Zhongguo Zhong.Yao Za Zhi 2008;33(23):2827-2829. View abstract.
Huang XF, Lu YL Fan XN Jiang M. Clinical observation of Puerarin for unstable angina pectoris. Journal of Medical Theory and Practice 2002;15(7):776-777.
Jang, M. H., Shin, M. C., Kim, Y. J., Chung, J. H., Yim, S. V., Kim, E. H., Kim, Y., and Kim, C. J. Protective effects of puerariaeflos against ethanol-induced apoptosis on human neuroblastoma cell line SK-N-MC. Jpn.J Pharmacol. 2001;87(4):338-342. View abstract.
Jeon, G. C., Park, M. S., Yoon, D. Y., Shin, C. H., Sin, H. S., and Um, S. J. Antitumor activity of spinasterol isolated from Pueraria roots. Exp Mol.Med 4-30-2005;37(2):111-120. View abstract.
Jiang RY. Clinical observation of 48 cases of puerarin for unstable angina pectoris. 2001;15(3):197-8. Journal of Xianning Medical College 2001;15(3):197-198.
Jiang, B., Liu, J. H., Bao, Y. M., and An, L. J. Hydrogen peroxide-induced apoptosis in pc12 cells and the protective effect of puerarin. Cell Biol.Int 2003;27(12):1025-1031. View abstract.
Jiang, R. W., Lau, K. M., Lam, H. M., Yam, W. S., Leung, L. K., Choi, K. L., Waye, M. M., Mak, T. C., Woo, K. S., and Fung, K. P. A comparative study on aqueous root extracts of Pueraria thomsonii and Pueraria lobata by antioxidant assay and HPLC fingerprint analysis. J Ethnopharmacol. 1-4-2005;96(1-2):133-138. View abstract.
Jiang, X. L. and Xu, L. N. [Beneficial effect of puerarin on experimental microcirculatory disturbance in mice]. Yao Xue.Xue.Bao. 1989;24(4):251-254. View abstract.
Jiang, X. X., Li, Y., and Wu, Y. B. [Effect of puerarin preconditioning on cytokine levels in patients undergoing cardiopulmonary bypass in perioperative period]. Zhongguo Zhong.Xi.Yi Jie.He.Za Zhi 2009;29(12):1089-1091. View abstract.
Jin, L. H., Liu, C. F., and Zeng, Y. [Protective effects of puerarin on radiation injury of experimental rats]. Zhong.Xi.Yi.Jie.He.Xue.Bao. 2005;3(1):43-45. View abstract.
Jin, M., Qin, J., and Wu, W. [Clinical study on Tianbaokang injection against oxidative injury of vascular endothelial function in ischemic apoplexy]. Zhong.Yao Cai. 2003;26(2):148-151. View abstract.
Jin, W. S., Tan, Y. Y., Chen, Y. G., and Wang, Y. [Determination of puerarin, daidzin and daidzein in root of Pueraria lobata of different origin by HPLC]. Zhongguo Zhong.Yao Za Zhi. 2003;28(1):49-51. View abstract.
Jung, D. Y., Ha, H., and Kim, C. Induction of growth hormone release by Pueraria thunbergiana BENTH. Horm.Metab Res. 2004;36(2):86-91. View abstract.
Kamiya, T., Takano, A., Matsuzuka, Y., Kusaba, N., Ikeguchi, M., Takagaki, K., and Kondo, K. Consumption of Pueraria flower extract reduces body mass index via a decrease in the visceral fat area in obese humans. Biosci.Biotechnol.Biochem. 2012;76(8):1511-1517. View abstract.
Kang, R. X. [The intraocular pressure depressive effect of puerarin]. Zhonghua Yan.Ke.Za Zhi. 1993;29(6):336-339. View abstract.
Kang, S. C., Lee, C. M., Choi, H., Lee, J. H., Oh, J. S., Kwak, J. H., and Zee, O. P. Evaluation of oriental medicinal herbs for estrogenic and antiproliferative activities. Phytother Res 2006;20(11):1017-1019. View abstract.
Kaufman, P. B., Duke, J. A., Brielmann, H., Boik, J., and Hoyt, J. E. A comparative survey of leguminous plants as sources of the isoflavones, genistein and daidzein: implications for human nutrition and health. J Altern Complement Med 1997;3(1):7-12. View abstract.
Keung, W. M. and Vallee, B. L. Daidzin and its antidipsotropic analogs inhibit serotonin and dopamine metabolism in isolated mitochondria. Proc.Natl.Acad.Sci.U.S.A 3-3-1998;95(5):2198-2203. View abstract.
Keung, W. M. and Vallee, B. L. Kudzu root: an ancient Chinese source of modern antidipsotropic agents. Phytochemistry 1998;47(4):499-506. View abstract.
Keung, W. M., Lazo, O., Kunze, L., and Vallee, B. L. Potentiation of the bioavailability of daidzin by an extract of Radix puerariae. Proc.Natl.Acad.Sci.U.S.A 4-30-1996;93(9):4284-4288. View abstract.
Keyler, D. E., Baker, J. I., Lee, D. Y., Overstreet, D. H., Boucher, T. A., and Lenz, S. K. Toxicity study of an antidipsotropic Chinese herbal mixture in rats: NPI-028. J Altern.Complement Med 2002;8(2):175-183. View abstract.
Kim, D. H., Jung, E. A., Sohng, I. S., Han, J. A., Kim, T. H., and Han, M. J. Intestinal bacterial metabolism of flavonoids and its relation to some biological activities. Arch Pharm.Res. 1998;21(1):17-23. View abstract.
Kim, D. H., Yu, K. U., Bae, E. A., and Han, M. J. Metabolism of puerarin and daidzin by human intestinal bacteria and their relation to in vitro cytotoxicity. Biol.Pharm.Bull. 1998;21(6):628-630. View abstract.
Kim, I. T., Park, Y. M., Shin, K. M., Ha, J., Choi, J., Jung, H. J., Park, H. J., and Lee, K. T. Anti-inflammatory and anti-nociceptive effects of the extract from Kalopanax pictus, Pueraria thunbergiana and Rhus verniciflua. J Ethnopharmacol. 2004;94(1):165-173. View abstract.
Kim, O. S., Choi, J. H., Soung, Y. H., Lee, S. H., Lee, J. H., Ha, J. M., Ha, B. J., Heo, M. S., and Lee, S. H. Establishment of in vitro test system for the evaluation of the estrogenic activities of natural products. Arch Pharm Res 2004;27(9):906-911. View abstract.
Kim, S. and Fung, D. Y. Antibacterial effect of crude water-soluble arrowroot (Puerariae radix) tea extracts on food-borne pathogens in liquid medium. Lett.Appl.Microbiol. 2004;39(4):319-325. View abstract.
Lamlertkittikul, S. and Chandeying, V. Efficacy and safety of Pueraria mirifica (Kwao Kruea Khao) for the treatment of vasomotor symptoms in perimenopausal women: Phase II Study. J Med Assoc Thai 2004;87(1):33-40. View abstract.
Lau, C. S., Carrier, D. J., Beitle, R. R., Howard, L. R., Lay, J. O., Liyanage, R., and Clausen, E. C. A glycoside flavonoid in Kudzu (Pueraria lobata): identification, quantification, and determination of antioxidant activity. Appl.Biochem.Biotechnol. 2005;121-124:783-794. View abstract.
Lee, D. S., Kim, Y. S., Ko, C. N., Cho, K. H., Bae, H. S., Lee, K. S., Kim, J. J., Park, E. K., and Kim, D. H. Fecal metabolic activities of herbal components to bioactive compounds. Arch Pharm.Res. 2002;25(2):165-169. View abstract.
Lee, H. W., Choo, M. K., Bae, E. A., and Kim, D. H. Beta-glucuronidase inhibitor tectorigenin isolated from the flower of Pueraria thunbergiana protects carbon tetrachloride-induced liver injury. Liver Int 2003;23(4):221-226. View abstract.
Lee, K. T., Sohn, I. C., Kim, Y. K., Choi, J. H., Choi, J. W., Park, H. J., Itoh, Y., and Miyamoto, K. Tectorigenin, an isoflavone of Pueraria thunbergiana Benth., induces differentiation and apoptosis in human promyelocytic leukemia HL-60 cells. Biol Pharm Bull 2001;24(10):1117-1121. View abstract.
Li X, Ni XQ Zhu YJ. Effect observation of puerarin plus heparin for senile unstable angina pectoris. Chinese Medicine of Factory and Mine 2002;15(5):420-421.
Li, B. and Yu, S. [Effect of puerarin on the bone metabolism in vitro]. Beijing Da.Xue.Xue.Bao. 2-18-2003;35(1):74-77. View abstract.
Li, N., Min, Z. D., and Wu, H. M. New oleanene-type triterpene saponins from Pueraria peduncularis. J Asian Nat.Prod.Res 2002;4(4):253-257. View abstract.
Li, X., Sun, S., and Tong, E. Experimental study on the protective effect of puerarin to Parkinson disease. J Huazhong.Univ Sci.Technolog.Med Sci. 2003;23(2):148-150. View abstract.
Liang, S., Xu, C., Li, G., and Gao, Y. P2X receptors and modulation of pain transmission: focus on effects of drugs and compounds used in traditional Chinese medicine. Neurochem.Int 2010;57(7):705-712. View abstract.
Lin, R. C., Guthrie, S., Xie, C. Y., Mai, K., Lee, D. Y., Lumeng, L., and Li, T. K. Isoflavonoid compounds extracted from Pueraria lobata suppress alcohol preference in a pharmacogenetic rat model of alcoholism. Alcohol Clin Exp.Res. 1996;20(4):659-663. View abstract.
Liu, J. M., Ma, L., and He, W. P. [Therapeutic effect of puerarin therapy on sudden deafness]. Di Yi Jun.Yi Da.Xue Xue Bao 2002;22(11):1044-1045. View abstract.
Liu, Q., Lu, Z., and Wang, L. Restrictive effect of puerarin on myocardial infarct area in dogs and its possible mechanism. J Tongji Med Univ 2000;20(1):43-45. View abstract.
Liu, Q., Wang, L., Lu, Z., Li, S., and Xiong, Y. [Effect of puerarin on coronary collateral circulation in dogs with experimental acute myocardial infarction]. Zhongguo Zhong.Yao Za Zhi. 1999;24(5):304-6, 320. View abstract.
Liu, X. J., Zhao, J., and Gu, X. Y. The effects of genistein and puerarin on the activation of nuclear factor-kappaB and the production of tumor necrosis factor-alpha in asthma patients. Pharmazie 2010;65(2):127-131. View abstract.
Lu, L., Liu, Y., Zhu, W., Shi, J., Liu, Y., Ling, W., and Kosten, T. R. Traditional medicine in the treatment of drug addiction. Am J Drug Alcohol Abuse 2009;35(1):1-11. View abstract.
Lu, X. R., Gao, E., Xu, L. Z., Li, H. Z., Kang, B., Chen, W. N., Chen, S. M., and Chai, X. S. [Blocking effect of puerarin on beta-adrenoceptors of isolated organs and the whole animal]. Zhongguo Yao Li Xue.Bao. 1986;7(6):537-539. View abstract.
Lu, X. R., Gao, E., Xu, L. Z., Li, H. Z., Kang, B., Chen, W. N., Chen, S. M., and Chai, X. S. Puerarin beta-adrenergic receptor blocking effect. Chin Med J (Engl.) 1987;100(1):25-28. View abstract.
Luo ZR, Gai XB Zheng WX Zheng B. Effect of puerarin on unstable angina pectoris and its coagulant, fibrinolytic and function of endothelial cells. Chinese Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care 2000;7(2):105-106.
Ma, L., Xiao, P., Guo, B., Wu, J., Liang, F., and Dong, S. [Cerebral protective effects of some compounds isolated from traditional Chinese herbs]. Zhongguo Zhong.Yao Za Zhi. 1999;24(4):238-inside. View abstract.
Malaivijitnond, S. Medical applications of phytoestrogens from the Thai herb Pueraria mirifica. Front Med 2012;6(1):8-21. View abstract.
Manonai, J., Chittacharoen, A., Theppisai, U., and Theppisai, H. Effect of Pueraria mirifica on vaginal health. Menopause. 2007;14(5):919-924. View abstract.
Manonai, J., Chittacharoen, A., Udomsubpayakul, U., Theppisai, H., and Theppisai, U. Effects and safety of Pueraria mirifica on lipid profiles and biochemical markers of bone turnover rates in healthy postmenopausal women. Menopause. 2008;15(3):530-535. View abstract.
McGregor, N. R. Pueraria lobata (Kudzu root) hangover remedies and acetaldehyde-associated neoplasm risk. Alcohol 2007;41(7):469-478. View abstract.
Meng, P., Zhou, D., and Hu, X. [Clinical observation of the treatment of infantile viral myocarditis with puerarin]. Zhongguo Zhong.Xi.Yi.Jie.He.Za Zhi. 1999;19(11):647-648. View abstract.
Mercer, L. D., Kelly, B. L., Horne, M. K., and Beart, P. M. Dietary polyphenols protect dopamine neurons from oxidative insults and apoptosis: investigations in primary rat mesencephalic cultures. Biochem.Pharmacol. 1-15-2005;69(2):339-345. View abstract.
Okamura, S., Sawada, Y., Satoh, T., Sakamoto, H., Saito, Y., Sumino, H., Takizawa, T., Kogure, T., Chaichantipyuth, C., Higuchi, Y., Ishikawa, T., and Sakamaki, T. Pueraria mirifica phytoestrogens improve dyslipidemia in postmenopausal women probably by activating estrogen receptor subtypes. Tohoku J Exp.Med 2008;216(4):341-351. View abstract.
Overstreet DH, Lee D Y-W, Chen YT, and et al. The Chinese herbal medicine NPI-028 suppresses alcohol intake in alcohol-preferring rats and monkeys without inducing taste aversion. Perfusion 1998;11:381-390.
Pan, H. P., Yang, J. Z., Li, L. L., Yi, F., Huang, Z. Q., and Huang, K. W. [Experimental study of puerarin injection on the hemorheology in acute blood-stasis model rats]. Zhongguo Zhong.Yao Za Zhi. 2003;28(12):1178-1180. View abstract.
Penetar, D. M., Maclean, R. R., McNeil, J. F., and Lukas, S. E. Kudzu extract treatment does not increase the intoxicating effects of acute alcohol in human volunteers. Alcohol Clin Exp.Res 2011;35(4):726-734. View abstract.
Penetar, D. M., Teter, C. J., Ma, Z., Tracy, M., Lee, D. Y., and Lukas, S. E. Pharmacokinetic profile of the isoflavone puerarin after acute and repeated administration of a novel kudzu extract to human volunteers. J Altern Complement Med 2006;12(6):543-548. View abstract.
Penetar, D. M., Toto, L. H., Farmer, S. L., Lee, D. Y., Ma, Z., Liu, Y., and Lukas, S. E. The isoflavone puerarin reduces alcohol intake in heavy drinkers: a pilot study. Drug Alcohol Depend. 11-1-2012;126(1-2):251-256. View abstract.
Prasain, J. K., Carlson, S. H., and Wyss, J. M. Flavonoids and age-related disease: risk, benefits and critical windows. Maturitas 2010;66(2):163-171. View abstract.
Prasain, J. K., Jones, K., Brissie, N., Moore, R., Wyss, J. M., and Barnes, S. Identification of puerarin and its metabolites in rats by liquid chromatography-tandem mass spectrometry. J Agric.Food Chem. 6-16-2004;52(12):3708-3712. View abstract.
Qi, B. L. and Qi, B. M. [Effect of the purariae-isofiavones on estrogen level in normal and ovariectomized rats]. Zhongguo Zhong.Yao Za Zhi. 2002;27(11):850-852. View abstract.
Qian, Y., Li, Z., Huang, L., Han, X., Sun, J., Zhou, H., and Liu, Z. Blocking effect of puerarin on calcium channel in isolated guinea pig ventricular myocytes. Chin Med J (Engl.) 1999;112(9):787-789. View abstract.
Qin, F., Huang, X., Zhang, H. M., and Ren, P. Pharmacokinetic comparison of puerarin after oral administration of Jiawei-Xiaoyao-San to healthy volunteers and patients with functional dyspepsia: influence of disease state. J Pharm Pharmacol 2009;61(1):125-129. View abstract.
Ren, P., Hu, H., and Zhang, R. [Observation on efficacy of puerarin in treating diabetic retinopathy]. Zhongguo Zhong.Xi.Yi.Jie.He.Za Zhi. 2000;20(8):574-576. View abstract.
Rezvani, A. H., Overstreet, D. H., Perfumi, M., and Massi, M. Plant derivatives in the treatment of alcohol dependency. Pharmacol.Biochem.Behav. 2003;75(3):593-606. View abstract.
Sang, H. F., Mei, Q. B., Xu, L. X., Wang, Q., Cheng, H., and Xiong, L. Z. Effect of puerarin on neural function and histopathological damages after transient spinal cord ischemia in rabbits. Chin J Traumatol. 2004;7(3):143-147. View abstract.
Shen, P., Liu, M. H., Ng, T. Y., Chan, Y. H., and Yong, E. L. Differential effects of isoflavones, from Astragalus membranaceus and Pueraria thomsonii, on the activation of PPARalpha, PPARgamma, and adipocyte differentiation in vitro. J Nutr 2006;136(4):899-905. View abstract.
Shen, Z. F. and Xie, M. Z. [Hypoglycemic effect of the combined use of puerarin and aspirin in mice]. Yao Xue.Xue.Bao. 1985;20(11):863-865. View abstract.
Shi, R. L. and Zhang, J. J. [Protective effect of puerarin on vascular endothelial cell apoptosis induced by chemical hypoxia in vitro]. Yao Xue.Xue.Bao. 2003;38(2):103-107. View abstract.
Shi, W. G., Qu, L., and Wang, J. W. [Study on interventing effect of puerarin on insulin resistance in patients with coronary heart disease]. Zhongguo Zhong.Xi.Yi.Jie.He.Za Zhi. 2002;22(1):21-24. View abstract.
Song, C. Y. and Bi, H. M. [Effects of puerarin on plasma membrane GLUT4 content in skeletal muscle from insulin-resistant Sprague-Dawley rats under insulin stimulation]. Zhongguo Zhong.Yao Za Zhi. 2004;29(2):172-175. View abstract.
Tam, W. Y., Chook, P., Qiao, M., Chan, L. T., Chan, T. Y., Poon, Y. K., Fung, K. P., Leung, P. C., and Woo, K. S. The efficacy and tolerability of adjunctive alternative herbal medicine (Salvia miltiorrhiza and Pueraria lobata) on vascular function and structure in coronary patients. J Altern Complement Med 2009;15(4):415-421. View abstract.
Tang YC, Qi JS. Effect observation of 30 cases of Pulelin for unstable angina pectoris. Journal of Medical Theory and Practice 1996;9(1):26-27.
Tomczyk, M., Zovko-Koncic, M., and Chrostek, L. Phytotherapy of alcoholism. Nat.Prod.Commun. 2012;7(2):273-280. View abstract.
Trisomboon, H., Malaivijitnond, S., Suzuki, J., Hamada, Y., Watanabe, G., and Taya, K. Long-term treatment effects of Pueraria mirifica phytoestrogens on parathyroid hormone and calcium levels in aged menopausal cynomolgus monkeys. J Reprod Dev. 2004;50(6):639-645. View abstract.
Trisomboon, H., Malaivijitnond, S., Watanabe, G., and Taya, K. Ovulation block by Pueraria mirifica: a study of its endocrinological effect in female monkeys. Endocrine. 2005;26(1):33-39. View abstract.
Virojchaiwong, P., Suvithayasiri, V., and Itharat, A. Comparison of Pueraria mirifica 25 and 50 mg for menopausal symptoms. Arch.Gynecol.Obstet. 2011;284(2):411-419. View abstract.
Wang DB, Long MZ Niu H. Clinical observation on puerarin in treating patients with unstable angina pectoris. Modern Journal of Integrated Chinese Traditional and Western Medicine 2001;10(17):1616-1617.
Wang Q, Hao LF. Effect of puerarin injection on plasmic endothelin and renin-angiotensin II in patients with unstable angina. Journal of Emergency Syndromes in Chinese Medicine 2000;4:151.
Wang Y, Li SG Wang X. Observation of the effects of 42 cases of "pulelin" injection for unstable angina pectoris. The Medical Journal of Industrial Enterprise 1997;10(1):40-41.
Wang, C. and Song, Z. In vitro monitoring of nanogram levels of puerarin in human urine using flow injection chemiluminescence. Bioorg.Med Chem.Lett. 8-16-2004;14(16):4127-4130. View abstract.
Wang, C. Y., Huang, H. Y., Kuo, K. L., and Hsieh, Y. Z. Analysis of Puerariae radix and its medicinal preparations by capillary electrophoresis. J Chromatogr.A 4-3-1998;802(1):225-231. View abstract.
Wang, C., Zhao, X., Mao, S., Wang, Y., Cui, X., and Pu, Y. Management of SAH with traditional Chinese medicine in China. Neurol.Res 2006;28(4):436-444. View abstract.
Wang, Q. and Xu, X. [Progresses in research of hemolysis induced by puerarin injection]. Zhongguo Zhong.Yao Za Zhi 2011;36(10):1402-1405. View abstract.
Wang, X., Wu, J., Chiba, H., Umegaki, K., Yamada, K., and Ishimi, Y. Puerariae radix prevents bone loss in ovariectomized mice. J Bone Miner.Metab 2003;21(5):268-275. View abstract.
Wen, K. C., Lin, S. P., Yu, C. P., and Chiang, H. M. Comparison of Puerariae Radix and its hydrolysate on stimulation of hyaluronic acid production in NHEK cells. Am J Chin Med 2010;38(1):143-155. View abstract.
Wong, K. H., Li, G. Q., Li, K. M., Razmovski-Naumovski, V., and Chan, K. Kudzu root: traditional uses and potential medicinal benefits in diabetes and cardiovascular diseases. J Ethnopharmacol. 4-12-2011;134(3):584-607. View abstract.
Wu, B., Liu, M., Liu, H., Li, W., Tan, S., Zhang, S., and Fang, Y. Meta-analysis of traditional Chinese patent medicine for ischemic stroke. Stroke 2007;38(6):1973-1979. View abstract.
Wu, P., Zeng, F., and Ma, H. X. [Study on effect of Puerarin on nitric oxide system in rats' tissue and its mechanism]. Zhongguo Zhong.Xi.Yi.Jie.He.Za Zhi. 2001;21(3):196-198. View abstract.
Wu, T. Q., Gu, N., and Wang, F. F. [Effect of ningxintong granule in treating patients of coronary heart disease with left ventricular diastolic dysfunction and qi-deficiency blood-stasis syndrome]. Zhongguo Zhong.Xi.Yi Jie.He.Za Zhi 2010;30(4):357-360. View abstract.
Wu, X. P., Feng, J. G., Chen, H. M., Cheng, F., Zhang, L., Wei, Z., and Chen, W. [Protective effects of puerarin against myocardial injury in patients with hypertension during perioperational period]. Zhongguo Zhong.Xi.Yi Jie.He.Za Zhi 2006;26(3):255-257. View abstract.
Xiao, L. Z., Gao, L. J., and Ma, S. C. [Comparative study on effects of puerarin and granulocyte colony-stimulating factor in treating acute myocardial infarction]. Zhongguo Zhong.Xi.Yi.Jie.He.Za Zhi. 2005;25(3):210-213. View abstract.
Xiao, L. Z., Huang, Z., Ma, S. C., Zen, Z., Luo, B., Lin, X., and Xu, X. [Study on the effect and mechanism of puerarin on the size of infarction in patients with acute myocardial infarction]. Zhongguo Zhong.Xi.Yi.Jie.He.Za Zhi. 2004;24(9):790-792. View abstract.
Xie, R. Q., Du, J., and Hao, Y. M. [Myocardial protection and mechanism of Puerarin Injection on patients of coronary heart disease with ischemia/reperfusion]. Zhongguo Zhong.Xi.Yi.Jie.He.Za Zhi. 2003;23(12):895-897. View abstract.
Xie, W. and Du, L. Diabetes is an inflammatory disease: evidence from traditional Chinese medicines. Diabetes Obes.Metab 2011;13(4):289-301. View abstract.
Xu, X. H. [Effects of puerarin on fatty superoxide in aged mice induced by D-galactose]. Zhongguo Zhong.Yao Za Zhi. 2003;28(1):66-69. View abstract.
Xu, X. H. and Zhao, T. Q. Effects of puerarin on D-galactose-induced memory deficits in mice. Acta Pharmacol.Sin. 2002;23(7):587-590. View abstract.
Xuan, B., Zhou, Y. H., Yang, R. L., Li, N., Min, Z. D., and Chiou, G. C. Improvement of ocular blood flow and retinal functions with puerarin analogs. J Ocul.Pharmacol.Ther. 1999;15(3):207-216. View abstract.
Xue, X. O., Jin, H., Niu, J. Z., and Wang, J. F. [Effects of extracts of root of kudzu vine on mammary gland and uterus development in rats]. Zhongguo Zhong.Yao Za Zhi. 2003;28(6):560-562. View abstract.
Yin, Z. Z. and Zeng, G. Y. [Pharmacology of puerarin. V. Effects of puerarin on platelet aggregation and release of 5-HT from platelets]. Zhongguo Yi.Xue.Ke.Xue.Yuan Xue.Bao. 1981;3 Suppl 1:44-47. View abstract.
Zhang SR, Liu GT Fang JP Hao YM Yan SC Dong L. Effect of puerarin on the endothelin and function of left ventricle in patients with unstable angina pectoris. Information on Traditional Chinese Medicine 2000;7(5):47-49.
Zhang, C., Liu, J., Pan, H., Yang, X., and Bian, K. [Mitochondrial dysfunction induced by excessive ROS/RNS-metabolic cardiovascular disease and traditional Chinese medicines intervention]. Zhongguo Zhong.Yao Za Zhi 2011;36(17):2423-2428. View abstract.
Zhang, G. and Fang, S. [Antioxidation of Pueraria lobata isoflavones (PLIs)]. Zhong.Yao Cai. 1997;20(7):358-360. View abstract.
Zhang, G. Q., Hao, X. M., Dai, D. Z., Fu, Y., Zhou, P. A., and Wu, C. H. Puerarin blocks Na+ current in rat ventricular myocytes. Acta Pharmacol.Sin. 2003;24(12):1212-1216. View abstract.
Zhang, S., Ji, G., and Liu, J. Reversal of chemical-induced liver fibrosis in Wistar rats by puerarin. J Nutr Biochem. 10-10-2005; View abstract.
Zheng, G., Zhang, X., Zheng, J., Meng, Q., and Zheng, D. [Estrogen-like effects of puerarin and total isoflavones from Pueraria lobata]. Zhong.Yao Cai. 2002;25(8):566-568. View abstract.
Zhou Y. A summary on 50 cases of unstable angina pectoris treated with combined therapy of Traditional Chinese and Western Medicine. Hunan Journal of Traditional Chinese Medicine 2003;19(2):4-5.
Zhu J, Cheng DH Yang Q Li WS. Clinical observation of puerarin in the treatment of old patients with unstable angina pectoris. Liaoning Drugs and Clinic 2001;4(1):17-18.
Zhu WM, Wu SY. Clinical therapeutic effects of nadroparin calcium combined with isosorbide dinitrate or puerarin on unstable angina pectoris. Chinese Journal of Clinical Pharmacy 2002;11(4):196-199.
Zhu, J. H., Wang, X. X., Chen, J. Z., Shang, Y. P., Zhu, J. H., Guo, X. G., and Sun, J. Effects of puerarin on number and activity of endothelial progenitor cells from peripheral blood. Acta Pharmacol.Sin. 2004;25(8):1045-1051. View abstract.
Zhu, X. Y., Su, G. Y., Li, Z. H., Yue, T. L., Yan, X. Z., and Wei, H. L. [The metabolic fate of the effective components of puerariae. III. The metabolism of puerarin (author's transl)]. Yao Xue.Xue.Bao. 1979;14(6):349-355. View abstract.
Zhu, Z. T., Li, H. Q., Lu, Y., Lou, J. S., and Yao, Z. [Inhibitive effect of puerarin on increased NO production by neonatal cardiomyocytes during hypoxia/reoxygenation injury]. Zhongguo Zhong.Yao Za Zhi. 2001;26(12):856-859. View abstract.
Zhuang, Z. and Jiang, G. Thirty cases of the blood-stasis type prolapse of lumbar intervertebral disc treated by acupuncture at the xi (cleft) point plus herbal intervention injection. J Tradit.Chin Med 2008;28(3):178-182. View abstract.
Akita H, Sowa J, Makiura M, et al. Maculopapular drug eruption due to the Japanese herbal medicine Kakkonto (kudzu or arrowroot decoction). Contact Dermatitis 2003;48:348-9.
Awang DV. Parthenocide: demise of a facile theory of feverfew activity. J Herbs Spices Med Plants 1998;5:95-8.
Benlhabib E, Baker JI, Keyler DE, Singh AK. Kudzu root extract suppresses voluntary alcohol intake and alcohol withdrawal symptoms in P rats receiving free access to water and alcohol. J Med Food 2004;7:168-79. View abstract.
Boue SM, Wiese TE, Nehls S, et al. Evaluation of the estrogenic effects of legume extracts containing phytoestrogens. J Agric Food Chem 2003;51:2193-9. View abstract.
Carai MA, Agabio R, Bombardelli E, et al. Potential use of medicinal plants in the treatment of alcoholism. Fitoterapia 2000;71:S38-42. View abstract.
Chen X. [The clinical observation of puerarin injection on unstable angina pectoris]. Zhong Yao Cai 2004;27:77-8. . View abstract.
Chiang HM, Fang SH, Wen KC, et al. Life-threatening interaction between the root extract of Pueraria lobata and methotrexate in rats. Toxicol Appl Pharmacol 2005;209:263-8. View abstract.
Chueh FS, Chang CP, Chio CC, Lin MT. Puerarin acts through brain serotonergic mechanisms to induce thermal effects. J Pharmacol Sci 2004;96:420-7. View abstract.
Guerra MC, Speroni E, Broccoli M, et al. Comparison between chinese medical herb Pueraria lobata crude extract and its main isoflavone puerarin antioxidant properties and effects on rat liver CYP-catalysed drug metabolism. Life Sci 2000;67:2997-3006. View abstract.
Heyman GM, Keung WM, Vallee BL. Daidzin decreases ethanol consumption in rats. Alcohol Clin Exp Res 1996;20:1083-7. View abstract.
Hsu FL, Liu IM, Kuo DH, et al. Antihyperglycemic effect of puerarin in streptozotocin-induced diabetic rats. J Nat Prod 2003;66:788-92. View abstract.
Kim HJ, Kim H, Ahn JH, Suk JH. Liver injury induced by herbal extracts containing mistletoe and kudzu. J Altern Complement Med 2015;21(3):180-5. View abstract.
Lee JS. Supplementation of Pueraria radix water extract on changes of antioxidant enzymes and lipid profile in ethanol-treated rats. Clin Chim Acta 2004;347:121-8. View abstract.
Lee KT, Sohn IC, Kim DH, et al. Hypoglycemic and hypolipidemic effects of tectorigenin and kaikasaponin III in the streptozotocin-lnduced diabetic rat and their antioxidant activity in vitro. Arch Pharm Res 2000;23:461-6. View abstract.
Li SM, Liu B, Chen HF. [Effect of puerarin on plasma endothelin, renin activity and angiotensin II in patients with acute myocardial infarction]. Zhongguo Zhong Xi Yi Jie He Za Zhi 1997;17:339-41. View abstract.
Lin RC, Li TK. Effects of isoflavones on alcohol pharmacokinetics and alcohol-drinking behavior in rats. Am J Clin Nutr 1998;68:1512S-5S. View abstract.
Lukas SE, Penetar D, Berko J, et al. An extract of the Chinese herbal root kudzu reduces alcohol drinking by heavy drinkers in a naturalistic setting. Alcohol Clin Exp Res 2005;29:756-62. View abstract.
Luo ZR, Zheng B. [Effect of Puerarin on platelet activating factors CD63 and CD62P, plasminogen activator inhibitor and C-reactive protein in patients with unstable angia pectoris]. Zhongguo Zhong Xi Yi Jie He Za Zhi 2001;21:31-3 . View abstract.
Overstreet DH, Kralic JE, Morrow AL, et al. NPI-031G (puerarin) reduces anxiogenic effects of alcohol withdrawal or benzodiazepine inverse or 5-HT2C agonists. Pharmacol Biochem Behav 2003;75:619-25. View abstract.
Prasain JK, Jones K, Kirk M, et al. Profiling and quantification of isoflavonoids in kudzu dietary supplements by high-performance liquid chromatography and electrospray ionization tandem mass spectrometry. J Agric Food Chem 2003;51:4213-8. View abstract.
Shebek J, Rindone JP. A pilot study exploring the effect of kudzu root on the drinking habits of patients with chronic alcoholism. J Altern Complement Med 2000;6:45-8. View abstract.
Tan Y, Liu M, Wu B. Puerarin for acute ischaemic stroke. Cochrane Syst Rev 2008;(1):CD004955. View abstract.
Wang B, Zhu YZ, Li XQ, et al. [Clinical analysis of 5 cases with acute intravascular hemolysis caused by puerarin]. Beijing Da Xue Xue Bao 2004;36:45-6.. View abstract.
Wang LY, Zhao AP, Chai XS. [Effects of puerarin on cat vascular smooth muscle in vitro]. Zhongguo Yao Li Xue Bao 1994;15:180-2. View abstract.
Wang Q, Wu T, Chen X, et al. Puerarin injection for unstable angina pectoris. Cochrane Database Syst Rev 2006;(3):CD004196. View abstract.
Weaver CM, Martin BR, Jackson GS, et al. Antiresorptive effects of phytoestrogen supplements compared with estradiol or risedronate in postmenopausal women using (41)Ca methodology. J Clin Endocrinol Metab 2009;94(10):3798-3805. View abstract.
Woo J, Lau E, Ho SC, et al. Comparison of Pueraria lobata with hormone replacement therapy in treating the adverse health consequences of menopause. Menopause 2003;10:352-61. View abstract.
Xie CI, Lin RC, Antony V, et al. Daidzin, an antioxidant isoflavonoid, decreases blood alcohol levels and shortens sleep time induced by ethanol intoxication. Alcohol Clin Exp Res 1994;18:1443-7. View abstract.
Yan B, Wang DY, Xing DM, et al. The antidepressant effect of ethanol extract of radix puerariae in mice exposed to cerebral ischemia reperfusion. Pharmacol Biochem Behav 2004;78:319-25. View abstract.
Yanagihara K, Ito A, Toge T, Numoto M. Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract. Cancer Res 1993;53:5815-21. View abstract.
Yang G, Zhang L, Fan L. [Anti-angina effect of puerarin and its effect on plasma thromboxane A2 and prostacyclin]. Zhong Xi Yi Jie He Za Zhi 1990;10:82-4,68. View abstract.
Ye HY, Qiu F, Zeng J, et al. [Effect of daidzein on antiarrhythmia]. Zhongguo Zhong Yao Za Zhi 2003;28:853-6. View abstract.
Yeh, T. S., Chan, K. H., Hsu, M. C., and Liu, J. F. Supplementation with soybean peptides, taurine, Pueraria isoflavone, and ginseng saponin complex improves endurance exercise capacity in humans. J Med Food 2011;14(3):219-225. View abstract.
Yu Z, Zhang G, Zhao H. [Effects of Puerariae isoflavone on blood viscosity, thrombosis and platelet function]. Zhong Yao Cai 1997;20:468-9. View abstract.
Zhang Y, Chen J, Zhang C, et al. Analysis of the estrogenic components in kudzu root by bioassay and high performance liquid chromatography.J Steroid Biochem Mol Biol 2005;94:375-81. View abstract.
Zhao Z, Yang X, Zhang Y. [Clinical study of puerarin in treatment of patients with unstable angina]. Zhongguo Zhong Xi Yi Jie He Za Zhi 1998;18:282-4. View abstract.
Zheng G, Zhang X, Zheng J, et al. [Hypocholesterolemic effect of total isoflavones from Pueraria lobata in ovariectomized rats]. Zhong Yao Cai 2002;25:273-5. View abstract.
Zhou Y, Su X, Cheng B, et al. [Comparative study on pharmacological effects of various species of Pueraria]. Zhongguo Zhong Yao Za Zhi 1995;20:619-21,640. View abstract.